2 hours Beam Therapeutics (NASDAQ:BEAM) Earns Sector Outperform Rating from Analysts at ScotiabankMarketBeat
Scotiabank began coverage on shares of Beam Therapeutics in a report on Wednesday. They issued a “sector outperform” rating on the stock.
XScotiabank began coverage on shares of Beam Therapeutics in a report on Wednesday. They issued a “sector outperform” rating on the stock.
X